SPDR S&P Biotech ETF $XBI Shares Sold by Canton Hathaway LLC

Canton Hathaway LLC cut its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 19.8% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 7,095 shares of the exchange traded fund’s stock after selling 1,750 shares during the quarter. Canton Hathaway LLC’s holdings in SPDR S&P Biotech ETF were worth $588,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in XBI. DHJJ Financial Advisors Ltd. acquired a new position in shares of SPDR S&P Biotech ETF during the 2nd quarter worth $25,000. Garrison Bradford & Associates Inc. acquired a new position in shares of SPDR S&P Biotech ETF during the 1st quarter worth $39,000. Compass Wealth Management LLC grew its stake in shares of SPDR S&P Biotech ETF by 46.0% during the 1st quarter. Compass Wealth Management LLC now owns 635 shares of the exchange traded fund’s stock worth $51,000 after purchasing an additional 200 shares during the period. Quaker Wealth Management LLC grew its stake in shares of SPDR S&P Biotech ETF by 101.2% during the 2nd quarter. Quaker Wealth Management LLC now owns 623 shares of the exchange traded fund’s stock worth $52,000 after purchasing an additional 53,536 shares during the period. Finally, Avalon Trust Co acquired a new position in shares of SPDR S&P Biotech ETF during the 1st quarter worth $57,000.

SPDR S&P Biotech ETF Stock Performance

XBI opened at $111.91 on Friday. The business’s fifty day moving average is $99.85 and its two-hundred day moving average is $88.92. The company has a market cap of $6.82 billion, a price-to-earnings ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a one year low of $66.66 and a one year high of $113.21.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.